Néovacs

Néovacs is a company listed under the stock ticker ALNEV (FR).

View the org chart displaying its 9 main executives

Most searched biographies at Néovacs

• Hugo Brugière, Chairman and Chief Executive Officer
• Baudouin Hallo, Director
• Daniel Zagury, Director

Create your alert
to follow the executive moves at Néovacs.

Néovacs has 2,298 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• AltruBio has just announced a $225 Million fundraising (posted on May 24 2024).
• Genmab has acquired ProfoundBio (posted on May 23 2024).
• Centivo has announced the acquisition of Eden Health  (posted on May 23 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Néovacs

• COMMUNIQUÉS DE PRESSE – Neovacs
• PRESS RELEASES – Neovacs

Social media about Néovacs

• Néovacs on Wikipedia, Google News & Yahoo Finance
• Néovacs on LinkedIn, Twitter & YouTube

Contact by email its executives including Hugo Brugière

Call Néovacs at +33 15...

View the org chart

Register to receive your alert

Report an error